Citation Tools

Download PDFPDF

LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia

Download to a citation manager

Cite this article as:
Murakhovskaya I, Fattizzo B, Ebrahim T, et al
LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia